Pfizer and Amgen are working on new GLP-1 shots designed to be taken once a month rather than weekly.
Berkeley Lovelace Jr. is a health and medical reporter at NBC News. He covers the Food and Drug Administration with a particular emphasis on Covid vaccines, prescription drug pricing, and the broader healthcare system, drawing on his previous experience in the biotech and pharmaceutical industry with CNBC. Berkeley's work has been featured in various outlets, including Yahoo News, NBC Bay Area, and WFLA News.

















